高级检索
当前位置: 首页 > 详情页

Age-stratified analysis of SARS-CoV-2 infection and case fatality rate in China, Italy, and South Korea

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Zhengzhou Univ, Affiliated Hosp 1, Dept Radiotherapy, Zhengzhou, Peoples R China [2]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan, Peoples R China [3]AMITA Hlth St Joseph Hosp Chicago, Dept Internal Med, Chicago, IL USA [4]Charite Univ Med Berlin, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany [5]Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometr & Epidemiol, Munich, Germany [6]Anhui Med Univ, Affiliated Hosp 2, Dept Urol, Hefei, Peoples R China [7]Saarland Univ, Med Ctr, Ctr Expt Orthopaed, Homburg, Germany
出处:
ISSN:

关键词: Coronavirus COVID-19 Pandemic Age Case fatality rate China Italy South Korea

摘要:
OBJECTIVE: We aimed to compare the characteristics of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China, Italy, and South Korea. MATERIALS AND METHODS: Detailed national epidemiological information of COVID-19 was retracted from the latest statistics reports from China, Italy, and South Korea. Population-based analysis of the age distribution among confirmed cases was conducted and their crude case fatality ratio in each c RESULTS: The age distributions among COVID-19 cases were relatively similar between China and Italy with primarily elderly populations infected, which were considerably different from that in South Korea with primarily younger individuals infected. Most deaths occurred among elderly individuals who were older than 60 years in both Italy (98.0%) and South Korea (87.9%), consistent with the previous data from China (81.0%). CONCLUSIONS: Most deaths occurred among elderly individuals who were over 60 in China, Italy, and South Korea. South Korea's data suggest that younger individuals might be more susceptible to SARS-CoV-2 infection, which might be fully under detected in China and Italy.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2025]版:
JCR分区:
出版当年[2018]版:
Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Zhengzhou Univ, Affiliated Hosp 1, Dept Radiotherapy, Zhengzhou, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:2 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)